Results 261 to 270 of about 36,022 (296)

Human GIP(3-30)NH inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors

Biochemical Pharmacology, 2018
Bolette Hartmann, Hans Bräuner-Osborne, Mette M. Rosenkilde   +2 more
exaly  

GIP contains the high affinity binding region of GIP and is a potent inhibitor of GIPaction in vitro

Regulatory Peptides, 1997
Michael B. Wheeler, Richard W Gelling, Raymond A Pederson   +2 more
exaly  

Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin

Diabetologia, 2003
Victor A. Gault, Peter R. Flatt, Finbarr O'Harte   +2 more
exaly  

Gips

1959
openaire   +1 more source

Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease

Peptides, 2020
Filip K Knop, Natasha C. Bergmann, Lærke S Gasbjerg   +2 more
exaly  

GIP analogues and the treatment of obesity-diabetes

Peptides, 2020
Clifford J Bailey
exaly  

Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia

Diabetologia, 2003
Jens Juul Holst, Michael A. Nauck, Juris Meier   +2 more
exaly  

GIP secretion inhibitor

2009
SUZUKI JUNKO, SHIMOTOYODOME AKIRA, ICHIBA TOMOHISA   +2 more
openaire   +3 more sources

Central administration of GLP-1 and GIP decreases feeding in mice

Biochemical and Biophysical Research Communications, 2017
Hyung Jin Choi, Cherl NamKoong, Min Sun Kim   +2 more
exaly  

Gips

1928
openaire   +1 more source